Docstoc

Aarkstore- The 2012 European Clinical Chemistry and Immunodiagnostics Markets

Document Sample
Aarkstore-  The 2012 European Clinical Chemistry and Immunodiagnostics Markets Powered By Docstoc
					  The 2012 European Clinical Chemistry and
         Immunodiagnostics Markets:
      France, Germany, Italy, Spain, UK
Emerging Opportunities and Business Expansion
                 Strategies
http://www.aarkstore.com/reports/The-2012-European-Clinical-Chemistry-and-Immunodiagnostics-
Markets-br-France-Germany-Italy-Spain-UK-br-Emerging-Opportunities-and-Business-Expansion-
Strategies-192924.html

This unique report provides information not available from any other published source, including
volume, sales, and leading supplier shares by test.

This market intelligence and technology assessment report will help current suppliers and potential
market entrants identify and evaluate emerging opportunities and develop effective strategic
responses. The report explores future trends in five major European countries (France, Germany,
Italy, Spain, UK) and Japan; provides estimates of the specimen, test and sales volumes, as well as
major suppliers’ sales and market shares; compares features of leading analyzers; profiles key
competitors; and identifies specific product and marketing opportunities emerging during the next
five years.

The clinical chemistry and immunodiagnostics markets are undergoing significant transformation,
caused by convergence of new and more stringent regulations; advances in diagnostic technologies,
system engineering, automation, and IT; and intensifying competition. Some segments, like routine
chemistry, begin to resemble commodity markets, where product positioning and cost per test are
more critical than underlying technology. This evolving marketplace creates exciting opportunities
for a variety of new instruments, reagent systems, and auxiliary products, such as specimen
preparation devices, controls, and calibrators.

Table of Contents :

A. Major Routine Chemistry Tests

1. Albumin

2. Alkaline Phosphatase

3. ALT/SGPT

4. Ammonia

5. Amylase

6. AST/SGOT

7. Bilirubin
8. Blood Gases

9. Blood Urea Nitrogen (BUN)

10. Calcium

11. Cholesterol

12. Cholinesterase

13. Creatinine

14. Electrolytes

a. Carbon Dioxide/Bicarbonate

b. Chloride

c. Potassium

d. Sodium

15. Fructosamine

16. Gamma-Glutamyl Transpeptidase (GGT)

17. Glucose

18. High Density Lipoprotein (HDL)

List of Tables

Major Companies Developing or Marketing

Albumin Tests

Major Companies Developing or Marketing

Alkaline Phosphatase Tests

Major Companies Developing or Marketing

ALT/SGPT Tests

Major Companies Developing or Marketing

Amylase Tests

Major Companies Developing or Marketing

AST/SGOT Tests

Major Companies Developing or Marketing
Bilirubin Tests

For Related reports Plz Follow the Link:

http://www.aarkstore.com/search/viewresults.asp?search=Immunodiagnostics
Markets&PubId=&pagenum=1

Related Reports:

The 2012 Drugs of Abuse Testing Market: US, Europe, Japan Test Volume and Sales Forecasts by
Country and Market Segment

The 2012 Endocrine Function Diagnostics Market: US, Europe, Japan Test Volume and Sales
Forecasts by Country and Market Segment

The 2012 Immunoprotein Diagnostics Market: US, Europe, Japan Test Volume and Sales Forecasts
by Country and Market Segment

The 2012 Clinical Chemistry and Immunodiagnostics Markets:Product Development Opportunities,
Market Penetration Strategies, Entry Barriers and Risks

The 2012 Therapeutic Drug Monitoring Market: US, Europe, Japan Test Volume and Sales Forecasts
by Country and Market Segment

From: Aarkstore Enterprise

Contact: Marketing Team(Jyoti)

Mob.No.918149852585/919272852585

Email: enquiry@aarkstore.com

URL: http://www.aarkstore.com/

http://in.linkedin.com/in/aarkstore

http://www.facebook.com/aarkstore

				
DOCUMENT INFO
Shared By:
Categories:
Stats:
views:12
posted:3/16/2012
language:English
pages:3
Description: This market intelligence and technology assessment report will help current suppliers and potential market entrants identify and evaluate emerging opportunities and develop effective strategic responses.